(Q71828085)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8941027%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

title

Concentration-related pharmacodynamic effects of thioridazine and its metabolites in humans (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8941027%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference

Hartigan-Go K

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8941027%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Bateman DN

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8941027%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Nyberg G

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8941027%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Mårtensson E

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8941027%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Thomas SH

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8941027%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

publication date

1 November 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8941027%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacology & Therapeutics

21 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8941027%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8941027%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8941027%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

page(s)

543-553

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8941027%20AND%20SRC:MED&resulttype=core&format=json

Mortality in a cohort of patients with schizophrenia: a record linkage study

21 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990150-2

QT dispersion and sudden unexpected death in chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990150-2

Electrocardiographic changes induced by phenothiazine drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990150-2

Electrocardiographic abnormalities induced by thioridazine (Mellaril)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990150-2

Cardiotoxic effects of Mellaril: conduction disturbances and supraventricular arrhythmias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990150-2

Phenothiazine-induced T-wave abnormalities. Effects of overnight fasting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990150-2

SUDDEN DEATH DURING TREATMENT WITH PHENOTHIAZINE DERIVATIVES.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990150-2

Thioridazine (mellaril)-induced ventricular tachycardia controlled with an artificial pacemaker

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990150-2

Death Associated With Ventricular Arrhythmia and Thioridazine Hydrochloride

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990150-2

Cardiovascular complications in young patients taking psychotropic drugs. A preliminary report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990150-2

Electrocardiographic changes and cardiac arrhythmias in patients receiving psychotropic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990150-2

Thioridazine-induced torsade de pointes. Successful therapy with isoproterenol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990150-2

Iatrogenic torsade de pointes induced by thioridazine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990150-2

Effects of thioridazine (Mellaril) on ventricular electrophysiologic properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990150-2

A survey of sudden death associated with the use of antipsychotic or antidepressant drugs: 49 cases in Finland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990150-2

Clinical pharmacology and pharmacokinetics of clonidine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990150-2

Some aspects of the effects of clobazam on human psychomotor performance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990150-2

The use of analogue scales in rating subjective feelings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990150-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990150-2

Plasma levels of thioridazine and metabolites are influenced by the debrisoquin hydroxylation phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990150-2

QT-interval prolonging drugs: mechanisms and clinical relevance of their arrhythmogenic hazards

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990150-2

Concentration dependent cardiotoxicity of terodiline in patients treated for urinary incontinence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990150-2

Stereoselective cardiotoxic effects of terodiline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990150-2

A pilot of plasma thioridazine and metabolites in chronically treated patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990150-2

Cardiotoxicity of thioridazine and two stereoisomeric forms of thioridazine 5-sulfoxide in the isolated perfused rat heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990150-2

Binding of thioridazine and thioridazine metabolites to serum proteins in psychiatric patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990150-2

Determination of thioridazine enantiomers in human serum by sequential achiral and chiral high-performance liquid chromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990150-2

Receptor affinity, neurochemistry and behavioral characteristics of the enantiomers of thioridazine: evidence for different stereoselectivities at D1 and D2 receptors in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990150-2

10.1016/S0009-9236(96)90150-2

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8941027%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8941027%20AND%20SRC:MED&resulttype=core&format=json